Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) FCF Margin (2016 - 2025)

Historic FCF Margin for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to 12.58%.

  • Xtant Medical Holdings' FCF Margin rose 262600.0% to 12.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.89%, marking a year-over-year increase of 190600.0%. This contributed to the annual value of 13.65% for FY2024, which is 16400.0% down from last year.
  • As of Q3 2025, Xtant Medical Holdings' FCF Margin stood at 12.58%, which was up 262600.0% from 2.57% recorded in Q2 2025.
  • In the past 5 years, Xtant Medical Holdings' FCF Margin ranged from a high of 12.58% in Q3 2025 and a low of 23.42% during Q1 2024
  • Its 5-year average for FCF Margin is 8.14%, with a median of 11.48% in 2022.
  • As far as peak fluctuations go, Xtant Medical Holdings' FCF Margin plummeted by -164300bps in 2022, and later surged by 262600bps in 2025.
  • Xtant Medical Holdings' FCF Margin (Quarter) stood at 1.45% in 2021, then crashed by -1131bps to 17.88% in 2022, then soared by 75bps to 4.55% in 2023, then skyrocketed by 100bps to 0.02% in 2024, then skyrocketed by 56713bps to 12.58% in 2025.
  • Its last three reported values are 12.58% in Q3 2025, 2.57% for Q2 2025, and 0.26% during Q1 2025.